Biogen Slips as Roche Spikes Alzheimer's Trials on Weak Data

(Bloomberg) -- Shares of Biogen Inc. came under pressure in trading before the U.S. market opened Wednesday after peer Roche Holding AG halted a pair of studies in Alzheimer’s disease as early data...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.